River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing.
River BioMedics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in January 2022.
River BioMedics's investors include BioGeneration Ventures, OostNL, KIKK Capital.
River BioMedics is headquartered in Enschede, The Netherlands.
River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing.
River BioMedics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"River BioMedics — Funding & Investors." VCBacked, January 20, 2022, https://www.vcbacked.co/company/river-biomedics. Accessed September 30, 2026.
VCBacked. (2022). River BioMedics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/river-biomedics
{{cite web |title=River BioMedics — Funding & Investors |url=https://www.vcbacked.co/company/river-biomedics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated